文献速递传染病防控与疫情报告卫生政策与健康促进

行为而非生物学因素驱动HIV阳性男男性行为者中的丙型肝炎病毒流行:包含丙肝治疗即预防影响的丙肝与HIV建模分析

Behavioural, not biological, factors drive the HCV epidemic among HIV-positive MSM: HCV and HIV modelling analysis including HCV treatment-as-prevention impact.
PubMed 文献 · Int J Epidemiol · 2017-01-01

研究使用联合MSM HIV/HCV传播模型,参数化自英国行为数据,探索生物学因素(HCV传染性增高、HIV阳性MSM自发清除率降低)和/或行为因素(按HIV status的优先性混合和性风险异质性)如何使HCV感染集中于HIV阳性MSM(HCV ratio为HIV阴性MSM的5-20倍)。结果显示生物学因素产生低HCV ratio(<3),不能解释偏斜流行;优先混合联合性风险异质性产生高HCV ratio(>10)且对两因素高度敏感。无论HCV ratio或行为/生物学因素如何,治疗HIV确诊MSM的HCV显著降低HIV阳性MSM的HCV患病率,但低HCV ratio时对全部MSM影响较小。结论认为性行为模式可能驱动观察到的HCV感染模式,这些模式变化可能使HCV传播至HIV阴性MSM,限制靶向HIV确诊MSM的HCV治疗即预防的影响。

要点

  • 生物学因素产生HCV ratio<3,不能解释HIV阳性MSM中HCV聚集。
  • 优先混合联合性风险异质性产生HCV ratio>10,且对两因素高度敏感。
  • 靶向治疗HIV确诊MSM的HCV在低HCV ratio时对全部MSM影响较小。

核心结论

  • 性行为模式可能驱动观察到的HIV阳性MSM中HCV感染模式,这些模式变化可能使HCV传播至HIV阴性MSM,限制靶向HIV确诊MSM的HCV治疗即预防的影响。

研究设计与样本

  • 使用联合MSM HIV/HCV传播模型,参数化自英国行为数据,探索生物学和/或行为因素如何使HCV感染集中于HIV阳性MSM,并探索不同HCV ratio下HCV治疗即预防的影响。

主要发现

  • 生物学因素产生低HCV ratio(<3),不能解释偏斜流行。
  • 优先混合联合性风险异质性产生高HCV ratio(>10),且对两因素高度敏感。
  • 无论HCV ratio或行为/生物学因素如何,治疗HIV确诊MSM的HCV显著降低HIV阳性MSM的HCV患病率。
  • 低HCV ratio时,治疗HIV确诊MSM的HCV对全部MSM的影响较小。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Uncertainty surrounds why hepatitis C virus (HCV) is concentrated among HIV-positive men who have sex with men (MSM). We used mathematical modelling to explore reasons for these infection patterns, and implications for HCV treatment-as-prevention. METHODS: Using a joint MSM HIV/HCV transmission model parameterized with UK behavioural data, we considered how biological (heightened HCV infectivity and reduced spontaneous clearance among HIV-positive MSM) and/or behavioural factors (preferential sexual mixing by HIV status and risk heterogeneity) could concentrate HCV infection in HIV-positive MSM as commonly observed (5-20 times the HCV prevalence in HIV-negative MSM; defined as the HCV ratio). We explored how HCV treatment-as-prevention impact varies under differing HCV ratios. RESULTS: Biological factors produced low HCV ratios (< 3), not explaining the skewed epidemic. However, combining preferential mixing by HIV status with sexual risk behaviour heterogeneity produced high HCV ratios (> 10) that were highly sensitive to both factors. Irrespective of the HCV ratio or behavioural/biological factors, HCV treatment of HIV-diagnosed MSM markedly reduced the HCV prevalence among HIV-positive MSM, but less impact was achieved among all MSM for lower HCV ratios. CONCLUSIONS: Sexual behaviour patterns likely drive observed HCV infection patterns among HIV-positive MSM. Changes in these patterns could disseminate HCV amongst HIV-negative MSM, limiting the impact of targeting HCV treatment to HIV-diagnosed MSM.

来源:Int J Epidemiol,查看原文。版权归原作者所有。

引用

  1. MacGregor L, Martin NK, Mukandavire C, et al. Behavioural, not biological, factors drive the HCV epidemic among HIV-positive MSM: HCV and HIV modelling analysis including HCV treatment-as-prevention impact. Int J Epidemiol. 2017. PMID: 28605503. doi:10.1093/ije/dyx075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。